Overview
This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.
Eligibility
Inclusion Criteria:
- Patients undergoing elective surgery under general anesthesia.
- American Society of Anesthesiologists grade 1, 2, or 3.
- Aged >18 years
Exclusion Criteria:
- Refusal to participate in the study
- Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
- History of neuromuscular disease.
- History of allergy to neuromuscular blockade
- Scheduled to transfer to the intensive care unit